DURING the past thirty years much useful progress has been made in the histological grading of malignant tumours of epithelial origin. This work, of which one practical application has been the attempted correlation of prognosis with histological structure of a tumour, has had many valuable results; and although there may be not infrequent discrepancies between the histological appreciation and the outcome of treatment in any given type of neoplasm, the results have at any rate led to some attempt being made by the histo-pathologist to guide the clinician at least in qualitative terms of high or low malignancy; and to more precise premises for the comnparison of differing methods of treatment in series of comparable cases.
DURING the past thirty years much useful progress has been made in the histological grading of malignant tumours of epithelial origin. This work, of which one practical application has been the attempted correlation of prognosis with histological structure of a tumour, has had many valuable results; and although there may be not infrequent discrepancies between the histological appreciation and the outcome of treatment in any given type of neoplasm, the results have at any rate led to some attempt being made by the histo-pathologist to guide the clinician at least in qualitative terms of high or low malignancy; and to more precise premises for the comnparison of differing methods of treatment in series of comparable cases.
The starting point of this present analysis was the observation that irrespective of the mode of treatment applied, the overall five year survival rates in most published dissections of groups of cases of osteogenic sarcomata were approxinmately of a similar order. A recent exception to this is contained in the analysis of a group of 415 malignant tumours involving bone published by Prevo (1950) . This large series included a group of 41 cases of osteogenic sarcoma confirmed by biopsy in which there were two 5-year survivals (4.9 per cent). The mean duration of symptoms prior to treatment in this series was 8-6 months, which is rather prolonged. In the small group in the Bristol Bone Tumour Register the mean time from the onset of symptoms to the time of clinical and radiological diagnosis was 4 4 months, and in the British Empire Cancer Campaign analysis (1949) it was shown that per cent of all cases attended for their first consultation in GRADING OP OSTEOGENIC SARCOMA It is noteworthy that two of the most valuable general works in this fieldGeschickter and Copeland's 'Tumours of Bone' (1949) and Coley's 'Neoplasms of Bone' (1949)-make no mention of histological grading of the tumours except in general terms, and although the latter subdivides cases into those of low, average and high malignancy, there is but little to indicate the histological features by which the differentiation can be made, other than the examination of cell morphology and stromal character. It is not infrequently the fashion to subdivide osteogenic sarcoma into a number of types-medullary and sub-periosteal, telangiectatic, sclerosing, periosteal, fibrosarcoma, chondrosarcoma, etc. This does not always seem profitable, and the writer is in accord with the opinion expressed by Willis (1948) on this point. Chondrosarcoma appears to differ in several major ways from the typical osteolytic anid osteoblastic osteogenic sarcoma. In its age incidence, main sites of origin, behaviour, its radiological and macroscopic appearances it appears to be characteristic, although in a broader sense it may be regarded as a variant of the osteogenic sarcoma group. For this reason the cases of chondrosarcoma in the Bristol Bone Tunmour Register have not been included in the series of tumours here examined.
On perusal of theliterature on osteogenic sarcoma it appears that where other attempts at histological grading have been made, e.g., Simmons (1939) , here again this has mainly been done on considerations of cell type and stromal characters. It is probable that these writers have been influenced by the approach of histologists to the group of fibro-sarcomata, where again the main histological grading has been based almost entirely upon cell morphology and the amount of stromal material produced by the neoplastic cells. This would seem to be the case in the grading of sarcomata adopted in such papers as those of Quick and Cutler (1927) , Grynfeltt (1929) , Geschickter (1932) , and Broders, Hargrave and Meyerding (1939) to mention a representative few.
The present position may be more clearly shown by quoting from a paper by Coley and Pool (1940) :
" Microscopically, the grade of malignancy is demonstrable by a uniformity of pleomorphism of the cell type, and we feel that in a given case, the most highly malignant area seen under the microscope should determine the grade". The latter point is undoubtedlv true, but it is suggested that the fundamental factor which dominates the selection of the "most highly malignant area" is only appreciated in a general way, i.e., the degree of mitotic activity of the neoplastic cells. It is a pathological truism to state that the presence of numerous mitotic nuclei in a section with concomitant atypism is indicative of a high degree of malignancy. The main purpose of this present paper is to define this well-appreciated fact in more precise terms and to focus attention more clearly upon its significance. Coley and Pool (1940) rightly draw attention to the other factors of a gross pathological nature which should influence the decision as to the grading of any particular sarcoma. The inspection of macroscopic pathology must largely be consequent upon either open operation, amputation or autopsy, and such details are not likely to be available to the histologist at the time of diagnosis. Some of these features can, it is true, be visualised by X-ray plates. However, the interpretation of these is mainly the proper province of the radiologist, and they are seldom to be seen in theroutine pathological laboratory. For the fortunate histo-pathologist who may be granted access to such aids, the position is onlyinmproved to such an extent as the experience which he may have in the interpretation of skiagrams, which is a field with 47 48 many pitfalls. The ideal state no doubt is the close liaison between surgeon, radiodiagnostician, radiotherapist and histologist with personal conference in each and every case. Such states of collaboration seldom exist under conditions of normal routine work.
The histological specimens from the present series of cases have been considered under the following headings:
1. Predominant cell type and its morphological characteristics; the type and amount of concomitant stroma.
2. The degree of nuclear mitotic activity present in selected areas of each sarcoma.
MATERIALS AND METHODS.
The cases comprise those which have been referred to the Bone Tumour Register during the 5-year-period 1946 to 1951. To anyone working in this field the fallacies of diagnosis are only too well known, and the cases included have all been subjected to free discussion and unanimous acceptance as osteogenic sarcoma by the group of radiologists, radiotherapists, surgeons and pathologists which forms the working panel of the Register. In each case the diagnosis has been based upon consideration of the full history, clinical examination, adequate skiagrams and histological sections. In some instances the histological material is derived from biopsy, in others from surgical or autopsy specimens. This has been indicated in Table I , also the time relationship of the histological specimen to any pre-operative X-radiation.
For histological purposes the specimens were fixed, cut and stained by the usual routine methods. The evaluation of the degree of mitotic activity for each tumour has been based upon the calculation of the Mitotic Ratio (M.R.). This is given as the ratio of resting nuclei to one cell nucleus in active mitosis, and for the purposes of this investigation a nucleus was considered to be in mitosis from the time of rupture of the nuclear membrane until the reformation in the cell of two or more complete daughter nuclei. Owing to the presence in sonle sections of many multinucleated tumour giant cells, and the indistinct outlines of a large proportion of the polyhedral cells, the nucleus was taken as the unit rather than the cell. In each case a minimum of 2500 neoplastic cell nuclei were examined in each section, using a ruled internal screen in one ocular of a binocular microscope. The fine ruling of this screen subdivided the central area of the observed field into 25 equal squares, which enabled accurate counting to be performed at a magnification of 500. In each case the examination was confined to the most cellular areas in the sections available of each tumour, these being selected by careful scanning with the lower power objectives.
Repeat examinations were made of a number of histological specimens with a view to determining the degree of reliability of the method used to evaluate the mitotic ratio of each tumour. Typical results of these counts are shown in Table  II . In each instance at least 2500 nuclei were examined. Two of these cases died at respectively 77 and 96 months with multiple pulmonary metastases, and the writer fully supports the view that 5 years is too short a period on which to base estimates of rate of cure in patients with osteogenic sarcoma.
These brief data may be compared with those published on larger series by the following: Christensen (1925), Coley and Pool (1940) , the results of the New York Memorial Hospital series mentioned by Coley (1949), Geschickter and Copeland (1949) , the series reported by the British Empire Cancer Campaign (1949), and Platt (1951) .
As may be expected with a relatively small group of cases, there are some differences from the larger published series, e.g., an unduly high incidence of femoral tumtours, but the broad agreement would suggest that this group may be regarded as a fair sample from which certain conclusions may tentatively be reached.
Clinical Grading of the Tumours. The data on which the clinical assessment of degree of malignancy has been based has been considered from the following points of view:
1. Total time of duration of the morbid process. The data shown in Table  III give the figures for each case as time in months. This has first been divided into two sections, ante-and post-diagnosis, and then the total combined timle of survival to the date of the last recorded examination of the patient.
2. Site of origin of the growth. 3. Age of the patient at time of onset of symptoms. 4. Complicating factors, e.g., other skeletal disease. 5. A radiological subdivision of the tumours into those which are mainly osteolytic or osteoblastic. The histological analysis will be discussed in respect of these factors under the appropriate sections.
In attempting to arrive at some appreciation of the clinical degree of malignancy of each individual tumour for purposes of comparison, it was decided that the best clinical guide available could be obtained from consideration of the growth rate of each sarconma, and also the total time of survival of each case fronm the date of presentation of the first relevant symptom. This method has certain inherent disadvantages, e.g., a tumour in an axial bone would prove more rapidly fatal than a similar one in the appendicular skeleton. It is also difficult to assess the influence of treatment upon the time of survival between diagnosis and death. Some indication of these factors is given later. In general terms the balance of prolonged life would be aweighted heavily in favour of the patient with a tumou'r distally situated in a limb bone, rather than the patient with a sarcoma of the axial skeleton. However, in terms of total effect of the tumour upon the host, the total survival time is probably the best means of measurement of relative clinical malignancy in this type of growth. 2. All these tumours (Grades I and II) have arisen in the appendicular skeleton.
3. The tumours of the axial skeleton have all been graded III. In the group of spindle-celled sarcomata listed in Table V the age difference does not appear to apply at all, and there were no tumours of this tvrpa in the series sited in the axial skeleton.
Histological Grading. The tumours have been graded I, II and III in ascending order of degree of malignancy, the annotation being largely based upon that adopted for tumours of epithelial origin. From considerations other than histological, e.g., site, concomitant skeletal disease, etc., it is possible also to indicate tumours which should also be regarded as Grade III plus. The various factors to be considered in the histological survey are compared with the clinical grading based upon the factors mentioned above.
Cell Type and Stroma. It is possible to divide the whole group of 36 sarcomata into two major subgroups according to the main cell type present. These are:
A. Polyhedral and angular-29 cases.
B. Spindle-celled or fusiform--7 cases.
A. Polyhedral-celled sarcomata. It is impossible here to escape the conclusion that the tumour-cell is primarily a neoplastic variant of the osteoblast. In a section of a well differentiated tumour the cells may show the somewhat basophilic cytoplasm and well-defined vesicular nucleus with 1 to 3 characteristic eosinophilic nucleoli seen in the normal osteoblast. The slight basophilia tends to diminish during mitotic activity, and the cell cytoplasm then stains a brighter pink with dyes of the eosin type. From observations on these tumours and other bony conditions, the writer has acquired the view that one of the essential functions of the osteoblast is the formation of osteoid tissue-the precursor of bone, from which under suitable conditions of substrate the formation of bone may occur, possibly with no further part being taken in the process by the osteoblast. Bone should be regarded as one of the end-products of a series of complicated and balanced chemical reactions, and modification of the several interacting factors may favour its deposition or dissolution. This view of the function of the osteoblast is largely in accord with that generally held, but modifies the function of the osteoblast as conceived by Leriche and Policard (1928) , who mainly attributed to this cell a reactive role.
It has been noted also, however, that the osteoblast may be phagocytic as mentioned by Leriche and Policard (1928) quoting Dubreuil (1910) , and by Bast (1924) .
It is not uncommon to see active osteoblasts " dusted " with blood pigment derived from adjacent haemorrhage. This is not infrequently found in young callus and in Paget's disease. It is also generally accepted that the osteoblast, both normal and neoplastic, may produce phosphatase. From the grounds that this cell therefore is actively concerned in the laying down of osteoid arises the essential stromal feature of this histological sub-type of osteogenic sarcoma, i.e., the characteristic osteoid stroma, which mav also be accompanied by considerable amounts of collagen and ill-formed cartilage. However, the osteoid is the essential feature. This stromal material may, however, sometimes occur in considerable amount in a tumour which is predominantly spindle-celled, but is then usually less evident than the collagenous fibrous matrix produced by the spindle cells. Under suitable conditions the osteoid matrix may either calcify or ossify, more often the latter, and then produce the appearance of the osteoblastic or sclerotic type of tumour. It is thus possible to subdivide this group further into i. Polyhedral-celled sarcom a-osteoblastic-22. ii.
Ditto -osteolytic -7. As may be expected, there is some overlapping in stromal composition between the polyhedral and spindle-celled groups. Of the seven tumours of the latter type in this series one could be classified as osteoblastic, the other six being osteolytic.
As the separation into blastic and lytic forms may largely depend on general radiological appearances, there is sometimes the difficulty of differentiating new tumour bone from new reactive bone and from calcified material. From the viewpoint of the histologist the essential histological structure of any neoplasmn occurring in a bone is more characteristically shown in an area of active growth, the radiological manifestations of which are more frequently lytic than blastic. Hence this feature of the amount of bony matrix is not always readily appreciable from even a large biopsy. For this reason this subdivision will not be pursued further in the present analysis; but it should be added, however, that a markedly bony stroma is often indicative of a tumour of relatively low malignancy, and this point should receive due consideration by the person who may attempt to correlate the histological, radiological and clinical findings in any particular case.
From inspection of Table IV the following points are evident: 1. The degree of cellularity of the tumour expressed in terms of the number of cells per standard field for the most cellular areas does not furnish any guide to the degree of malignancy.
2. Cellular pleomorphism is generally, but not invariably, an indication of a tumour of high-grade malignancy.
3. The converse relationship, whilst often observ-ed, has numerous exceptions. 4 . In an approximately quantitative assessment of the amount of osteoid stroma present in these sarcomata it is seen that there is usually a rich matrix in tumours of lower grade malignancv, and conversely a relatively smaller amount in the high-grade group. There are noteworthy exceptions, and the specimens showing perhaps this stromal feature in the greatest degree were those from BTR /66, R. D-, which were relatively acellular but had a well-developed matrix. Where this osteoid tissue is well developed it is usual for much of it eventually to ossify. There is some evidence suggesting that nuclear activity in a cell is accompanied by a lowered pH of the cytoplasm, possibly also producing some change also in the extracellular substrate in which the cells lie. Swenson (1946) GRADING OF OSTEOGENIC SARCOMA has shown that a low pH in a haematoma is associated with bone resorption in the region of a fracture. It appears therefore likely that the more acid tissue fluid which may exist in the region of rapid tumour growth is one of the factors which would influence the extent to which the osteoid stroma would be ossified. In support of this assertion it can be pointed out that it was a nunmber of those tumours which showed a slow growth rate as evidenced by their mitotic ratio and clinical survival (Nos. 6, 26, 39, 43 and 203) that showed the most marked bone formation in their sections. There was also a moderate amount of bone present in the stromal tissues of Nos. 66, 213, 221 and 226, but generally this feature was less evident in the more actively growing tumours. It is emphasized that a change in pH of the substrate is only one of a number of factors concerned in this biochemical change. It is also wise to bear in mind a fallacy that may arise in sampling a bony tumour, as the more easily sectioned and hence less bony areas are frequently selected for routine diagnostic examination.
Quite a nuimber of these sarcomata also show chondroid stromal areas which may either calcify or ossify, both changes often being seen in adjacent areas and largely governed by two factors: 1. Suitability of the substrate. ii. Modification of the fine collagenous fibres of the chondroid material into a form which is denser and stranded, this change apparently being brought about by osteoblasts. In the absence of this latter change, the cartilage responds to its environment by calcification. In several tumours there were also patches of mucinous material, and all these stromal variants are indicative of the wide potential biochemical ability of the ancestral stem cell, the fibroblast. These features do not appear to have any special significance, from the viewpoint of grading. 5 . The iimean mitotic ratio of these sarcomata decreases as one passes from clinical Grade I to Grade III, This is mluch more evident in the separation of clinical Grade I from the tumours of Grades II and III. It may be noted here that based upon clinical data case BTR/136, Y. M-, has been graded I. It is not unlikely that this tumour should be re-graded II in view of the low mitotic ratio, and suggests that the long survival of this patient was a result of the prompt amputation which followed upon diagnosis. In this case the time period between the presenting symptom and radical operation was only one month, and the case may be regarded as a considerable surgical success.
B. Spindle-celled group.
These sarcomata, as compared with the polyhedral-celled group, are generally of a more uniform cellular structure. Tumour giant cells and nmultinucleated giant cells of distorted osteoclast type are much less frequently seen. Histogenetically they appear to be related to the fibroblast, which even in its neoplastic variant appears on occasion to be able to modify itself to becomie an osteoblast and form some irregular osteoid stroma. This feature was evident in 3 out of the 7 growths included in this sub-group, and in one of the tumours (BTR/157, D. J. A-) there was produced also a sufficient amount of new bone to warrant its classification as an osteoblastic osteogenic sarcoma.
The inultipotent ability of the fibroblast which shows itself in the occasional appearance of some amount of osteoid, bony or chondroid stroma was recognised by the American Registry of Bone Sarcoma in their 1939 (revised) classification, and they continued to regard intrinsic fibro-sarcoma as a variant of the osteogenic group (Ewing, 1939) . Jaffe (1947), on the other hand, commenting upon this adheres to the stricter view and classifies fibro-sarcoma as a separate entity. From consideration of the small group of cases here reported it would seem that this differentiation is indistinct and serves no useful purpose. Table V gives details of these 7 cases. This grouip is far too small to be the basis for any definite conclusions, but the following tentative points emerge:
1. From considerations of cell morphology, stroma, and number of cells per unit area of the most cellular parts of the tumour in the sections examined, it is not possible to arrive at any useful histological grading.
2. On direct comparison by grades with the tumours in the polyhedral-celled group, those of the spindle-celled type show rather less stromal material, are on average somewhat more cellular but less pleomorphic, are mainly osteolytic, and the average time of survival of the patient afflicted with this type of bone sarcoma is rather longer in Grade II and about the same in Grade III.
3. The mean growth rates of these tumours graded clinically II and III in (Table IV) . 4 . In the spindle-celled group there were no tumours which appeared to merit a clinical or histological grading of I on comparison with those of the larger polyhedral-celled series. This appears to be confirmed on considering the figures obtained for the mitotic ratio in these growths.
. Group B. Spindle-celled (7) . 20-9 months + . 128 1 . 392 6. One may perhaps from this draw the conclusion that there is some evidence to suggest that in a series of these two histological types of osteogenic sarconma if composed of tumours of average or more than average malignancy that the tinme of survival is rather longer in favour of the spindle-celled type. In this small series of cases, one obvious difficulty that has arisen has been the determination of mean survival time of the sub-groups, and it is fully appreciated that the figures shown are only minimal inasmuch as cases have been included which are still living. Where this has been done, it has been indicated bv the presence of a plus sign after the figure denoting survival time in months. The inclusion of such cases was thought to be justifiable in view of the marked difference which can be shown in the prognosis in cases given a histological grading of I when the problem is approached purely from the histological angle. This is dealt with in the next section.
Analysis of Mitotic Activity of Whole Group of 36 Sarcomata.
It is widely known that a feature of the degree of malignancy of any tumour is the number of mitoses that can be observed in the nucleii of the component cells. It is also known that sarcomata, both spontaneous and experimental, are mainly characterised by continued increase of tumour size, rather than by invasion of adjacent tissues. This continued growth is partly due to the multiplication of the nuinber of cells of the tumour. For the purposes of this analysis it has been assumed that the mitotic ratio is an index of the growth rate of this series of sarcomata. Table III gives details of age, site, type of tumour, mitotic ratio and total duration of survival for the whole group.
From this table 9O cases can be selected in which the period of time between the appearance of the initial symptom and diagnosis is greater than 6 months. These are cases Nos. 26, 39, 81, 96, 102, 2"03, 317, 337 and 338, and all the patients had tumours of the appendicular skeleton. On reference to Table III again it will be seen that 7 of the 9 tuiyours showed a mitotic ratio considerably greater than the average for their appropriate clinical grade. Mean Converselv one may likewise select the type of case showing the other extreme, i.e., there were 11 cases in which the time period between onset of symptoms and diagnosis was one month or less. Mean figures for this group are given below. (Cases Nos. 10, 61, 66, 70, 83, 136, 145, 163, 213, 221, 250.) There is obviously some overlapping of individual figures between the two groups, and 2 tumours of the axial skeleton are included in the latter larger number.
Subject to individual differences in tolerance of patients and speed of diagnostic methods, one may assume that the more rapidly growing tunmour will lead to the earlier synmptomatology in tumours of a similar primary site. That being so, the difference in the degree of mitotic activitv of the two groups of tumours is striking, as also is the difference in the mean time of survival of the former group as compared with the latter; and whilst 5 of the formier group are still living, there is only one survivor in the latter group. This degree of agreement between the mitotic ratio, ante-diagnostic period and total time of survival helps to render more evident the fallacy in the conclusion reached by Ferguson (1940) , and supports the more reasonable explanation given by Colev (1949) , that tne more slowly growing tumour produces the less alarming symptoms. It would seem niore rational to associate urgency of treatment with tumours of more rapid growth, i.e., Grades II and III, in which grades of malignancy the survival rates will be minimal, by whatever lneans the cases are at present treated. Per contra, in tumours of Grade I malignancv, occasional cures ma-y be expected by radiotherapy only, e.g., No. 26, N. G-, and it is strongly suggested that the aoverning factor in the survival of any case of osteogenic sarcoma is the combination of site of origin and histological grading of the tumour. Table VI shows the 36 cases of osteogenic sarcoma arranged in ascending order according to the mitotic ratio, i.e., in order of diminishing mitotic activity.
This has been subdivided into three purely histological grades of malignancy, 61 into those cases with a mitotic ratio less than 100:1, from 100:1 to 400:1, and greater than 400:1. This may be taken as approximnating to those of greater, average and lesser degrees of nuclear activity. Reference back to Tables IV and V will show that all the cases there clinically graded as III appear again as Grade III (histological) plus one case, BTR/157, D. J. A-, which was clinically graded II. Group based on range of mitotic ratio greater than 400.
Mean survival of Grade I (7) -75v 1 + months. Six still living (85.6 per cent.).
The correlation coefficient for the whole series has been calculated for the two variates months of survival and mitotic ratio. The value obtained for r was 0 6156. Table VI includes all those cases formerlv given a clinical grading of II, plus one case BTR/136, Y. M--, formerly given a clinical grading of I and 8 others (Nos. 10, 70, 102, 169, 198, 221, 226, 299) which had been clinically graded III.
Histological Grade II in
The 7 cases graded I (histological) in Table VI have in each instance been given a clinical grading of the same value.
It is evident then that on this basis any histological sub-division into Grades II and III is indistinct, and not always in accord with the clinical interpretation of such cases.
In the misfit in Grade III (histological) of Table VI (BTR/157, D. J. A-) the possible explanation can again be offered that the clinical grading based upon the consideration of survival time and other factors has been influenced by the treatment given to the patient. Table VII shows the cases listed in Table VI as Grade II (histological) divided into those which appear as Grades II and III (clinical) in Tables IV and V. These two groups have been respectively designated Groups X and Y, and on comparison of these the following points can be seen:
Group X (Grade II histological, Grade III clinical).
1. The average age in this group is markedly higher than in Group Y, 51-6 years as compared with 28 9 years.
2. Excluding case BTR/299, F. H. B-, who is still alive and may eventually qualify for a more favourable clinical grading, the cases are with one exception all tumours of the axial skeleton, or of the upper end of the proximal long bone of a limb.
3. In the case of BTR/226, A. R. 0-, the sarcoma at autopsy was of small size, but had produced collapse of a dorsal vertebra with marked angulation of the spine and compression of the cord. This may be compared with BTR/143, J. H--, in which a vertebral sarcoma occupied a more dorsi-lateral position and produced a very much larger soft tissue mass beneath the erector spinae muscles. These observations emphasize the bearing of the factor of site uipon the clinical interpretation of any attempt to grade these tumours histologically. 4 the date of the first symptom. However, even with this small group of cases it is evident that it is unusual for a long period of survival to be associated with a mitotic ratio of the tumour falling within the maximum observed range of 43:1 to 92:1. This feature can be well appreciated from Fig. 2 , which depicts the per cent survival by years of the cases in the three histological grades of Table VI .
Histological Grade I of Table VI . It would appear from the tabular data that it is possible to distinguish histologically in a series of cases of osteogenic sarcoma those tumours which may be graded I (histological). The mean mitotic ratio for the whole group of 36 sarcomata was 238:1 cell nuclei. If one selects as a separate group (P) the 7 cases in which the mitotic ratio is markedly greater than the average the following figures are obtained (No. 6, 26, 35, 39, 43, 203, 317 The marked difference in the prognosis in these separated groups of cases can again be well seen from Fig. 2 . It would be of the greatest value to subject many further cases to this type of analysis, to confirm if possible the significance of the mitotic ratio and to find its mean value based upon the examination of a much larger series of tumours. The number of sarcomata found in this present series of 36 tumours in which the mitotic ratio is appreciably greater than the mean figure is per cent of the total. It will be noted that this figure is approximately of the same order as the 5-year survival rate (21-4 per cent). Reference 5 to Table I shows the treatment which was given to these 7 cases. As can be seen, surgical success may occur in the treatment of cases of higher-grade malignancy (II and III), but such is unusual. The analysis presented above suggests that calculation of the mitotic ratio at the time of diagnosis by the pathologist will enable him to indicate the grade of his histological malignancy, and hence some idea of the prognosis may be determinable for any particular case with more certainty. If this method can be firmly established it should be of great assistance in the difficult decision over upper limb amputations. There are 3 such cases in this series (No. 26, 203 and 317) , 2 of which have been treated by radiotherapy only, and one by radiotherapy followed after 18 months by diaphysectomy on account of renewed and progressive pain. In cases No. 26 and 203 a good prognosis can be given with reasonable confidence; this, however, is rather more guarded in case No. 317 in view of the patient's advanced age and concomitant Paget's disease, although in this latter case the site in the lower end of the radius of the tumour does not suggest a rapidly fatal issue.
In view of the figures given for the mitotic ratio in this group of sarcomata, it is interesting to compare these with figures obtained for similar investigations on non-neoplastic specimens. (Table VIII) . In each of these specimens of tissue there was marked cellular functional activity with the formation of much new osteoid and bone. The mitotic ratio in all these specimens is of a different order from those found in the general run of the group of osteogenic sarcomata. Apart from the histological features, appreciation of this fact may be of considerable assistance when attempting to reach a decision on an atypical section of bony material. That the very slightly greater degree of mitotic activity was found here related to the osteoblast, and not the fibroblast, if confirmable, will strengthen the concept of the histogenesis of the polyhedral-celled type of osteogenic sarcoma, and support the assertion of Geschickter and Copeland (1949) that such tumours are derived from osteoblasts.
CONCLUSIONS.
1. The series of cases of osteogenic sarcoma here reported, although small in number, appears to conform with the main features of much larger groups formerly published.
2. By the application of histological methods only, it is possible to grade these sarcomata I, II and III in ascending order of malignancy, the scheme adopted being applicable to tumours of either predominantly a polyhedral or spindle-celled sub-type.
3. The amount and type of tumour matrix, whilst of some indicative value, are not reliable criteria for assessing the histological grade of these growths.
